Toolkit/AAV2-retro

AAV2-retro

Taxonomy: Mechanism Branch / Architecture. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

Using the 2020 review on intersectional AAV targeting as the anchor, the strongest enrichment leads are the primary method papers that the review explicitly builds on: the engineered retrograde capsid AAV2-retro (Tervo et al., 2016).

Usefulness & Problems

No literature-backed usefulness or problem-fit explainer has been materialized for this record yet.

Published Workflows

Objective: Systematically identify and characterize engineered ocular and neurotropic AAV capsids tested in non-human primates from the published literature.

Why it works: The review describes a structured search over PubMed abstracts using specific entity and context terms, followed by refinement to a smaller relevant set, allowing a large literature to be narrowed into a tractable translational summary.

enhanced tissue and cell-specific targetingnatural language processingPubMed abstract queryingliterature refinementlarge language model-assisted characterization

Stages

  1. 1.
    PubMed abstract query and broad retrieval(in_silico_filter)

    This stage captures a broad initial literature set using structured query terms relevant to capsids, route, and biological context.

    Selection: Specific mentions of AAVs, administration routes, and organ/tissue/species in PubMed abstracts

  2. 2.
    Optimized refinement to relevant unique abstracts(hit_picking)

    This stage narrows a very large initial search result into a tractable set of abstracts suitable for systematic review and translational synthesis.

    Selection: Relevance and uniqueness after an optimized refinement process

  3. 3.
    Route-based characterization and synthesis of engineered capsids(functional_characterization)

    Organizing findings by administration route supports translational interpretation of where different engineered capsids may be most useful.

    Selection: Summarization of novel capsids by administration route: systemic CNS targeting, direct CNS injection, and ocular administration

Steps

  1. 1.
    Query PubMed abstracts for AAV, route, and organ or species termsliterature-mining method

    Generate a broad candidate literature set relevant to engineered ocular and neurotropic AAV capsids tested in non-human primates.

    A broad search is needed first to capture the rapidly growing literature before narrowing to a curated evidence set.

  2. 2.
    Refine initial hits to relevant and unique abstracts

    Reduce the broad search output to a manageable and nonredundant set for review synthesis.

    Refinement follows broad retrieval so that downstream characterization is performed on a focused evidence set rather than on thousands of raw hits.

  3. 3.
    Summarize retained capsids by administration route and translational attributescharacterization aid

    Organize the final evidence set into route-specific categories and summarize translationally relevant capsid properties.

    Route-based synthesis is performed after refinement so that interpretation focuses on the most relevant and unique abstracts.

Objective: Target AAV-mediated gene expression to discrete neuron populations defined by axonal connectivity in order to dissect neural circuits.

Why it works: The review states that these approaches use axonal connectivity logic to restrict AAV-mediated expression to discrete neuron populations, allowing circuit-specific labeling and manipulation.

axonal transportintersectional restriction by defined inputs and outputsAAV-mediated gene deliveryintersectional targeting

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Architecture: A delivery strategy grouped with the mechanism branch because it determines how a system is instantiated and deployed in context.

Target processes

selection

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1payload scopesupports2020Source 1needs review

Intersectional AAV circuit-targeting approaches can target expression of fluorescent reporters, optogenetic ion channels, chemogenetic receptors, disease-associated proteins, and other factors to defined neural circuits.

These approaches can precisely target the expression of fluorescent reporters, optogenetic ion channels, chemogenetic receptors, disease-associated proteins, and other factors to defined neural circuits
Claim 2review scope summarysupports2020Source 1needs review

The review covers axonal-transport-based intersectional AAV approaches for targeting neuron populations defined by connectivity.

We review emerging techniques that use the axonal transport of adeno-associated virus (AAV) vectors to dissect neural circuits. These intersectional approaches specifically target AAV-mediated gene expression to discrete neuron populations based on their axonal connectivity
Claim 3tool role summarysupports2020Source 1needs review

AAV1-mediated anterograde transsynaptic tagging is presented in the supplied source summary as a basis for input-defined and input-plus-output-defined circuit targeting schemes discussed by the review.

forming the basis of input-defined and input+output-defined circuit targeting schemes discussed in the review
Claim 4tool role summarysupports2020Source 1needs review

AAV2-retro is presented in the supplied source summary as a key engineered retrograde capsid enabling output-defined intersectional targeting strategies discussed by the review.

the engineered retrograde capsid AAV2-retro (Tervo et al., 2016)
Claim 5tool role summarysupports2020Source 1needs review

INTRSECT is presented in the supplied source summary as a multi-recombinase Boolean expression framework connected to reviewed intersectional AAV approaches.

introducing the multi-recombinase Boolean expression framework explicitly connected to reviewed intersectional AAV approaches

Approval Evidence

2 sources1 linked approval claimfirst-pass slug aav2-retro
Notable findings include numerous novel capsids summarized by route of administration: (2) direct central nervous system injection (e.g., AAV2.Retro, Olig001, and AAV2.1A).

Source:

Using the 2020 review on intersectional AAV targeting as the anchor, the strongest enrichment leads are the primary method papers that the review explicitly builds on: the engineered retrograde capsid AAV2-retro (Tervo et al., 2016).

Source:

tool role summarysupports

AAV2-retro is presented in the supplied source summary as a key engineered retrograde capsid enabling output-defined intersectional targeting strategies discussed by the review.

the engineered retrograde capsid AAV2-retro (Tervo et al., 2016)

Source:

Comparisons

No literature-backed comparison notes have been materialized for this record yet.

Ranked Citations

  1. 1.
    StructuralSource 1Journal of Neuroscience Research2020Claim 1Claim 2Claim 3

    Extracted from this source document.